Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column
Authors:
- Tom TeerlinkTTTom Teerlink
- 1 June 2006
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 353 (2) , 287-289
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery DiseaseCirculation Research, 2005
- Applications of silica‐based monolithic HPLC columnsJournal of Separation Science, 2004
- Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary interventionEuropean Heart Journal, 2003
- Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortalityClinical Nutrition, 2003
- Association of Asymmetric Dimethylarginine and Endothelial DysfunctionClinical Chemistry and Laboratory Medicine (CCLM), 2003
- Determination of Arginine, Asymmetric Dimethylarginine, and Symmetric Dimethylarginine in Human Plasma and Other Biological Samples by High-Performance Liquid ChromatographyAnalytical Biochemistry, 2002
- Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyThe Lancet, 2001
- Risk of acute coronary events and serum concentration of asymmetrical dimethylarginineThe Lancet, 2001
- Does ADMA Cause Endothelial Dysfunction?Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992